A22.0 is a billable and specific ICD-10 Diagnosis code for cutaneous anthrax.
Accurate use of A22.0 helps healthcare professionals properly diagnose the condition, manage treatment effectively, and ensure correct insurance billing.
Purpose of This Guideline
This guide explains:
- The official use of A22.0
- ICD-10-CM coding guidelines
- The historical background of this diagnosis code
What is the ICD-10-CM Diagnosis Code for Cutaneous anthrax?
The ICD-10-CM diagnosis code for Cutaneous anthrax is A22.0.
Anthrax is a serious infectious disease caused by the bacterium Bacillus anthracis. It can affect the skin, lungs, or digestive system and is most commonly spread through contact with infected animals or animal products.
Cutaneous anthrax is the most common and mildest form. It occurs when Bacillus anthracis spores enter the body through a cut or break in the skin.
Signs and Symptoms
Early symptoms include:
- A small, itchy bump resembling an insect bite
- The bump develops into a painless sore with a black center
- Surrounding swelling and fever may follow
It is usually caused by handling infected animals or animal hides. Early treatment leads to full recovery and prevents complications.
Diagnosis and Treatment
Doctors diagnose cutaneous anthrax through skin culture tests, blood tests, and other laboratory methods. Prompt treatment is essential to prevent complications.
Common treatments include:
- Ciprofloxacin
- Doxycycline
- Amoxicillin (in mild cases)
With early antibiotic use, most patients recover fully within a few weeks.
Proper documentation using A22.0 ensures patients receive appropriate care and enables accurate healthcare reimbursement.
History Background of ICD-10-CM Diagnosis Code A22.0
The ICD-9-CM system, first introduced in 1979, provided the initial framework for coding diseases and health-related conditions in the United States.
The ICD-9-CM diagnosis code for Cutaneous anthrax was 022.0.This coding remained consistent from 1979 to 2015.
While the ICD-9-CM system offered a basic approach to disease classification, modern healthcare needs more detail and specificity.
To address this, the ICD-10-CM system was launched in 2015, introducing a more comprehensive and accurate coding structure.
The transition from ICD-9-CM to ICD-10-CM significantly improved the ability to document and analyze conditions such as Cutaneous anthrax.
The 2025 edition of ICD-10-CM A22.0 became effective on October 1, 2024.
| Year | ICD-10-CM Code | Description |
| 2020 | A22.0 | No Change |
| 2021 | A22.0 | No Change |
| 2022 | A22.0 | No Change |
| 2023 | A22.0 | No Change |
| 2024 | A22.0 | No Change |
| 2025 | A22.0 | No Change |
Why Accurate Documentation Using A22.0 Matters
Using code A22.0 ensures:
- Proper diagnosis
- Timely treatment
- Precise medical documentation
- Accurate healthcare reimbursement
Additionally, it supports epidemiological tracking and public health surveillance.
Other ICD-10-CM Diagnosis Codes in A22
ICD-10-CM code A22 | Anthrax has following sub categories including A22.0 :
- A22 Anthrax.
- A22.0 Cutaneous anthrax.
- A22.1 Pulmonary anthrax.
- A22.2 Gastrointestinal anthrax.
- A22.7 Anthrax sepsis.
- A22.8 Other forms of anthrax.
- A22.9 Anthrax, unspecified.
Final Thoughts
Proper coding of A22.0 is essential for diagnosing and managing Cutaneous anthrax. A clear understanding of its history, and correct usage enhances medical documentation and ensures effective treatment, patient care, supports healthcare planning, and guarantees proper reimbursement for medical services.
